• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Non-surgical outpatient treatment for CIN shows promise

byDenise PongandLeah Hawkins Bressler, MD, MPH
November 29, 2014
in Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with CIN-2 who were treated with hexaminolevulinate 5% photodynamic therapy showed histological improvement.

2. This treatment method also demonstrated efficacy at clearance of HPV in patients with CIN-2.

Evidence Rating Level: 1 (Excellent)  

Study Rundown: Worldwide, cervical cancer is the leading causes of cancer death for women. Existing practices, such as the human papillomavirus (HPV) vaccine and routine screening with Pap smears, reduce the incidence of and facilitate early identification of cervical malignancies. Cervical intraepithelial neoplasia (CIN) is a precursor to malignancy identified on cytology. Among women over 24 years old, current guidelines recommend observation for low-grade (CIN-1), as many of these lesions regress on their own. Those with high-grade lesion (CIN-2 or 3) are recommended to undergo excision by conization or loop electrosurgical excision procedure. While effective in removing pre-malignant or localized malignant lesions, these procedures are not without morbidity and may increase risk for preterm birth. Previous work has shown that hexaminolevulinate (HAL) photodynamic therapy (PDT) is effective in treating CIN. The present study is the first to evaluate the efficacy, safety, dosing and side effects of an outpatient HAL PDT treatment. Authors found that HAL PDT was effective in managing CIN-2 with minor side effects.

Strengths of the study included a double-blinded, randomized controlled trial study design. Limitations included a relatively short follow-up period and patient removal of the device, which may have resulted in minor variations in treatment time with HAL PDT. Future work should include Phase 3 trials in a larger population. Longer-term follow up would assess for sustained response to treatment and identify long-term adverse effects.

Click to read the study in AJOG

Relevant Reading: Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate–a double-blind, dose-finding study

RELATED REPORTS

Optimized vitamin C levels may be associated with mitigated HPV infection risk

Human papillomavirus infection is associated with adenocarcinoma of the cervix [Classics Series]

Human papillomavirus (HPV) vaccination rates have increased in recent years

In-Depth [randomized controlled trial]: This study evaluated the efficacy of HAL PDT in treatment of women with CIN-1 or CIN-2. Women were randomized to receive either placebo (n=68), HAL 0.2% (n=62), HAL 1% (n=67) or HAL 5% (n=65). Outcomes of interest were clinical response to treatment, defined as normal histology or low-grade cytology with clearance of oncogenic HPV infection present at baseline and adverse effects.

In patients with CIN-2, those receiving HAL 5% showed a 95% response rate (p=0.009) at 3 months and 6 months. This group also demonstrated better clearance of HPV, with 62% clearance at 3 months and 77% clearance at 6 months compared to 28% and 39% in the placebo group, respectively, though these differences were not statistically significant. A greater proportion of patients receiving HAL 5% reported experiencing adverse side effects, the most common of which were discharge, local discomfort and spotting.

More from this author: Obstetric scoring systems overestimate cases of severe sepsis, Vitamin D deficiency linked to preeclampsia, Cervical ripening with isosorbide mononitrate linked to increased side effects

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: cervical cancerhpv
Previous Post

Possible risk factors for sphenoid sinus tumor recurrence identified

Next Post

Patient Basics: Endocarditis

RelatedReports

Citrus consumption associated with malignant melanoma
Infectious Disease

Optimized vitamin C levels may be associated with mitigated HPV infection risk

October 13, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Obstetrics and Gynecology Classics

Human papillomavirus infection is associated with adenocarcinoma of the cervix [Classics Series]

September 15, 2022
Mental health parity law associated with financial protection for children
Chronic Disease

Human papillomavirus (HPV) vaccination rates have increased in recent years

June 23, 2022
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Next Post

Patient Basics: Endocarditis

RAS mutation linked with survival in metastatic colorectal cancer

CT colonography may help distinguish chronic diverticular disease from cancer

Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Nanoparticles may reduce impact of neurological injury [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Metformin use may decrease risk of osteoarthritis development
  • Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease
  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options